# N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy

> **NCT00637624** · NA · TERMINATED · sponsor: **Rijnstate Hospital** · enrollment: 69 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Small Cell Lung
- Mesothelioma

## Interventions

- **DRUG:** N-Acetylcysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00637624
- **Lead sponsor:** Rijnstate Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-03
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 69 (ACTUAL)
- **Why stopped:** Unable to recruit enough patients
- **Last updated:** 2022-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00637624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00637624, "N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00637624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*